JUDITH HELLER: Open Payments
NPI 1134191604 · ANSONIA, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 45 payments from 9 companies in 2025. Trend: 2023 $1,239 · 2024 $1,018 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $396 |
| GlaxoSmithKline, LLC. | 10 | $186 |
| Lilly USA, LLC | 2 | $32 |
| Astellas Pharma US Inc | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: VRAYLAR, TRELEGY ELLIPTA, UBRELVY, SHINGRIX, Veozah, Wegovy, ELIQUIS, FREESTYLE LIBRE 3.
Industry payments across CT — which companies pay providers there.
